A quinoxaline-based derivative exhibited potent and selective anticancer activity with apoptosis induction in PC-3 cells through Topo II inhibition

References

• Abbas, H.-A. S., Al-Marhabi, A. R., Eissa, S. I., & Ammar, Y. A. (2015). Molecular modeling studies and synthesis of novel quinoxaline derivatives with potential anticancer activity as inhibitors of c-Met kinase. Bioorganic & Medicinal Chemistry, 23(20), 6560–6572. https://doi.org/10.1016/j.bmc.2015.09.023
   PubMed Web of Science ®Google Scholar
• Abd-Elhamid, R., Nazmy, M., & Fathy, M. (2020). Targeting apoptosis as a therapeutic approach in cancer. Minia Journal of Medical Research, 31(2), 321–334. https://doi.org/10.21608/mjmr.2022.221093
   Google Scholar
• Adeshina, A., & Solomon, J. (2014). Urea and Creatinine of clarias gariepinus in three commercial ponds.
   Google Scholar
• Ahmed, M. F., & Almalki, A. H. (2021). Design, synthesis, anti-proliferative activity, and cell cycle analysis of new thiosemicarbazone derivatives targeting ribonucleotide reductase. Arabian Journal of Chemistry, 14(3), 102989. https://doi.org/10.1016/j.arabjc.2021.102989
   Web of Science ®Google Scholar
• Ahmed, M. H., El-Hashash, M. A., Marzouk, M. I., & El-Naggar, A. M. (2020). Synthesis and antitumor activity of some nitrogen heterocycles bearing pyrimidine moiety. Journal of Heterocyclic Chemistry, 57(9), 3412–3427. https://doi.org/10.1002/jhet.4061
   Web of Science ®Google Scholar
• Ahmed, E. A., Mohamed, M. F. A., Omran, A., & Salah, H. (2020). Synthesis, EGFR-TK inhibition and anticancer activity of new quinoxaline derivatives. Synthetic Communications, 50(19), 2924–2940. https://doi.org/10.1080/00397911.2020.1787448
   Web of Science ®Google Scholar
• Ajani, O. O., Nlebemuo, M. T., Adekoya, J. A., Ogunniran, K. O., Siyanbola, T. O., & Ajanaku, C. O. (2019). Chemistry and pharmacological diversity of quinoxaline motifs as anticancer agents. Acta Pharmaceutica (Zagreb, Croatia), 69(2), 177–196. https://doi.org/10.2478/acph-2019-0013
   PubMed Web of Science ®Google Scholar
• Alanazi, M. M., Elwan, A., Alsaif, N. A., Obaidullah, A. J., Alkahtani, H. M., Al-Mehizia, A. A., Alsubaie, S. M., Taghour, M. S., & Eissa, I. H. (2021). Discovery of new 3-methylquinoxalines as potential anticancer agents and apoptosis inducers targeting VEGFR-2: Design, synthesis, and in silico studies. Journal of Enzyme Inhibition and Medicinal Chemistry, 36(1), 1732–1750. https://doi.org/10.1080/14756366.2021.1945591
   PubMed Web of Science ®Google Scholar
• AlDubayan, S. H. (2019). Leveraging clinical tumor-profiling programs to achieve comprehensive germline-inclusive precision cancer medicine. Journal of Clinical Oncology Precision Oncology, 3(3), 1–3. https://doi.org/10.1200/PO.19.00108
   PubMedGoogle Scholar
• Al-Mutairi, F. M., Abdel-Daim, M. M., Ibrahim, I. T., Habib, S. A., & Waly, H. M. (2016). The Potent Effect of a Newly Synthesized N-Butylpyridoquinoxaline 1,4-dioxide (NBPQD) Derivative as Antitumor agent in solid tumor model.
   Google Scholar
• Alsaif, N. A., Dahab, M. A., Alanazi, Mohammed, M., Obaidullah, A. J., Al-Mehizia, A. A., Alanazi, Manal, M., Aldawas, S., Mahdy, H. A., & Elkady, H. (2021). New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis. Bioorganic Chemistry, 110, 104807. https://doi.org/10.1016/j.bioorg.2021.104807
   PubMed Web of Science ®Google Scholar
• Anic, K., Schmidt, M. W., Schmidt, M., Krajnak, S., Löwe, A., Linz, V. C., Schwab, R., Weikel, W., Brenner, W., Westphalen, C., Rissel, R., Hartmann, E. K., Conradi, R., Hasenburg, A., & Battista, M. J. (2022). Impact of perioperative red blood cell transfusion, anemia of cancer and global health status on the prognosis of elderly patients with endometrial and ovarian cancer. Frontiers in Oncology, 12, 967421. https://doi.org/10.3389/fonc.2022.967421
   PubMed Web of Science ®Google Scholar
• Bonilla-Ramirez, L., Rios, A., Quiliano, M., Ramirez-Calderon, G., Beltrán-Hortelano, I., Franetich, J. F., Corcuera, L., Bordessoulles, M., Vettorazzi, A., López de Cerain, A., Aldana, I., Mazier, D., Pabón, A., & Galiano, S. (2018). Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies. European Journal of Medicinal Chemistry, 158, 68–81. https://doi.org/10.1016/j.ejmech.2018.08.063
   PubMed Web of Science ®Google Scholar
• Boraei, A. T. A., Eltamany, E. H., Ali, I. A. I., Gebriel, S. M., & Nafie, M. S. (2021). Synthesis of new substituted pyridine derivatives as potent anti-liver cancer agents through apoptosis induction: In vitro, in vivo, and in silico integrated approaches. Bioorganic Chemistry, 111, 104877. https://doi.org/10.1016/j.bioorg.2021.104877
   PubMed Web of Science ®Google Scholar
• Buergy, D., Wenz, F., Groden, C., & Brockmann, M. A. (2012). Tumor–platelet interaction in solid tumors. International Journal of Cancer, 130(12), 2747–2760. https://doi.org/10.1002/ijc.27441
   PubMed Web of Science ®Google Scholar
• Carneiro, B. A., & El-Deiry, W. S. (2020). Targeting apoptosis in cancer therapy. Nature Reviews. Clinical Oncology, 17(7), 395–417. https://doi.org/10.1038/s41571-020-0341-y
   PubMed Web of Science ®Google Scholar
• Chen, C., Lu, L., Yan, S., Yi, H., Yao, H., Wu, D., He, G., Tao, X., & Deng, X. (2018). Autophagy and doxorubicin resistance in cancer. Anti-Cancer Drugs, 29(1), 1–9. https://doi.org/10.1097/CAD.0000000000000572
   PubMed Web of Science ®Google Scholar
• Clarke, H., & Pallister, C. J. (2005). The impact of anaemia on outcome in cancer. Clinical and Laboratory Haematology, 27(1), 1–13. https://doi.org/10.1111/j.1365-2257.2004.00664.x
   PubMedGoogle Scholar
• de Gaetano, M., Tighe, C., Gahan, K., Zanetti, A., Chen, J., Newson, J., Cacace, A., Marai, M., Gaffney, A., Brennan, E., Kantharidis, P., Cooper, M. E., Leroy, X., Perretti, M., Gilroy, D., Godson, C., & Guiry, P. J. (2021). Asymmetric synthesis and biological screening of quinoxaline-containing synthetic lipoxin A4 mimetics (QNX-sLXms). Journal of Medicinal Chemistry, 64(13), 9193–9216. https://doi.org/10.1021/acs.jmedchem.1c00403
   PubMed Web of Science ®Google Scholar
• Desplat, V., Vincenzi, M., Lucas, R., Moreau, S., Savrimoutou, S., Pinaud, N., Lesbordes, J., Peyrilles, E., Marchivie, M., Routier, S., Sonnet, P., Rossi, F., Ronga, L., & Guillon, J. (2016). Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1,2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines. European Journal of Medicinal Chemistry, 113, 214–227. https://doi.org/10.1016/j.ejmech.2016.02.047
   PubMed Web of Science ®Google Scholar
• Eissa, I. H., Metwaly, A. M., Belal, A., Mehany, A. B. M., Ayyad, R. R., El-Adl, K., Mahdy, H. A., Taghour, M. S., El-Gamal, K. M. A., El-Sawah, M. E., Elmetwally, S. A., Elhendawy, M. A., Radwan, M. M., & ElSohly, M. A. (2019). Discovery and anti-proliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors. Arch Pharm (Weinheim), 352(11), e1900123. https://doi.org/10.1002/ardp.201900123
   PubMed Web of Science ®Google Scholar
• El Newahie, A. M. S., Ismail, N. S. M., Abou El Ella, D. A., Abouzid K., & A. M. (2016). Quinoxaline-based scaffolds targeting tyrosine kinases and their potential anticancer activity. Archiv Der Pharmazie, 349(5), 309–326. https://doi.org/10.1002/ardp.201500468
   PubMed Web of Science ®Google Scholar
• El Newahie, A. M. S., Nissan, Y. M., Ismail, N. S. M., Abou El Ella, D. A., Khojah, S. M., & Abouzid K. A. M. (2019). Design and synthesis of new quinoxaline derivatives as anticancer agents and apoptotic inducers. Molecules (Basel, Switzerland), 24(6), 1175. https://doi.org/10.3390/molecules24061175
   PubMed Web of Science ®Google Scholar
• El Rayes, S. M., Aboelmagd, A., Gomaa, M. S., Ali, I., A. I., Fathalla, W., Pottoo, F. H., & Khan, F. A. (2019). Convenient synthesis and anticancer activity of methyl 2-[3-(3-phenyl-quinoxalin-2-ylsulfanyl)propanamido]alkanoates and N-alkyl 3-((3-Phenyl-quinoxalin-2-yl)sulfanyl)propanamides. ACS Omega, 4(20), 18555–18566. https://doi.org/10.1021/acsomega.9b02320
   PubMed Web of Science ®Google Scholar
• El-Atawy, M. A., Hamed, E. A., Alhadi, M., & Omar, A. Z. (2019). Synthesis and antimicrobial activity of some new substituted quinoxalines. Molecules (Basel, Switzerland), 24(22), 4198. https://doi.org/10.3390/molecules24224198
   PubMed Web of Science ®Google Scholar
• El-Metwally, S. A., Abou-El-Regal, M. M., Eissa, I. H., Mehany, A. B. M., Mahdy, H. A., Elkady, H., Elwan, A., & Elkaeed, E. B. (2021). Discovery of thieno[2,3-d]pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anticancer agents. Bioorganic Chemistry, 112, 104947. https://doi.org/10.1016/j.bioorg.2021.104947
   PubMed Web of Science ®Google Scholar
• Elmore, S. (2007). Apoptosis: A review of programmed cell death. Toxicologic Pathology, 35(4), 495–516. https://doi.org/10.1080/01926230701320337
   PubMed Web of Science ®Google Scholar
• Estes, J. M., Leath, C. A., Williams, S., Modiano, M. R., Sawyer, M., Cohn, D., Straughn, J. M., Barnes, M. N., & Alvarez, R. D. (2006). Efficacy and toxicity of the novel chemotherapeutic agent KW-2170 in recurrent epithelial ovarian cancer. Gynecologic Oncology, 102(2), 338–342. https://doi.org/10.1016/j.ygyno.2005.12.031
   PubMed Web of Science ®Google Scholar
• Fan, D., Liu, P., Jiang, Y., He, X., Zhang, L., Wang, L., & Yang, T. (2022). Discovery and SAR study of quinoxaline–arylfuran derivatives as a new class of antitumor agents. Pharmaceutics, 14(11), 2420. https://doi.org/10.3390/pharmaceutics14112420
   PubMed Web of Science ®Google Scholar
• Fayed, E. A., Ammar, Y. A., Ragab, A., Gohar, N. A., Mehany, A. B. M., & Farrag, A. M. (2020). In vitro cytotoxic activity of thiazole-indenoquinoxaline hybrids as apoptotic agents, design, synthesis, physicochemical and pharmacokinetic studies. Bioorganic Chemistry, 100, 103951. https://doi.org/10.1016/j.bioorg.2020.103951
   PubMed Web of Science ®Google Scholar
• Ferrão, J. B., Sardinha, M. P., & Dutra, E. (2021). Hyperleukocytosis in solid tumors: a rare paraneoplastic syndrome associated with poor prognosis. The American Journal of the Medical Sciences, 362(2), 211–214. https://doi.org/10.1016/j.amjms.2021.01.027
   PubMed Web of Science ®Google Scholar
• Franco, P., Montagnani, F., Arcadipane, F., Casadei, C., Andrikou, K., Martini, S., Iorio, G. C., Scartozzi, M., Mistrangelo, M., Fornaro, L., Cassoni, P., Cascinu, S., Ricardi, U., & Casadei Gardini, A. (2018). The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer. Radiation Oncology, 13(1), 83. https://doi.org/10.1186/s13014-018-1035-9
   PubMedGoogle Scholar
• Ghanavat, M., Ebrahimi, M., Rafieemehr, H., Maniati, M., Behzad, M. M., & Shahrabi, S. (2019). Thrombocytopenia in solid tumors: Prognostic significance. Oncology Reviews, 13(1), 413. https://doi.org/10.4081/oncol.2019.413
   PubMed Web of Science ®Google Scholar
• Goldar, S., Khaniani, M. S., Derakhshan, S. M., & Baradaran, B. (2015). Molecular mechanisms of apoptosis and roles in cancer development and treatment. Asian Pacific Journal of Cancer Prevention: APJCP, 16(6), 2129–2144. https://doi.org/10.7314/APJCP.2015.16.6.2129
   PubMedGoogle Scholar
• Habib, S. A., Ibrahim, I. T., Abd-Eldaye, M. A., El-Sheshtawey, M. M., & Waly, H. M. (2012). N-Butylpyridoquinoxaline 1,4-dioxide (NBPQD) as a new potent for tumor imaging and therapy. Natural Science, 04(12), 1074–1084. https://doi.org/10.4236/ns.2012.412136
   Google Scholar
• Haffner, M. C., Aryee, M. J., Toubaji, A., Esopi, D. M., Albadine, R., Gurel, B., Isaacs, W. B., Bova, G. S., Liu, W., Xu, J., Meeker, A. K., Netto, G., De Marzo, A. M., Nelson, W. G., & Yegnasubramanian, S. (2010). Androgen-induced TOP2B mediated double strand breaks and prostate cancer gene rearrangements. Nature Genetics, 42(8), 668–675. https://doi.org/10.1038/ng.613
   PubMed Web of Science ®Google Scholar
• Hajri, M., Esteve, M.-A., Khoumeri, O., Abderrahim, R., Terme, T., Montana, M., & Vanelle, P. (2016). Synthesis and evaluation of in vitro anti-proliferative activity of new ethyl 3-(arylethynyl)quinoxaline-2-carboxylate and pyrido[4,3-b]quinoxalin-1(2H)-one derivatives. European Journal of Medicinal Chemistry, 124, 959–966. https://doi.org/10.1016/j.ejmech.2016.10.025
   PubMed Web of Science ®Google Scholar
• Hamdy, R., Elseginy, S. A., Ziedan, N. I., Jones, A. T., & Westwell, A. D. (2019). New quinoline-based heterocycles as anticancer agents targeting Bcl-2. Molecules (Basel, Switzerland), 24(7), 1274. https://doi.org/10.3390/molecules24071274
   PubMed Web of Science ®Google Scholar
• Hughes, C., Murphy, A., Martin, C., Fox, E., Ring, M., Sheils, O., Loftus, B., & O'Leary, J. (2006). Topoisomerase II‐α expression increases with increasing Gleason score and with hormone insensitivity in prostate carcinoma. Journal of Clinical Pathology, 59(7), 721–724. https://doi.org/10.1136/jcp.2005.029975
   PubMed Web of Science ®Google Scholar
• Ibrahim, M. K., Taghour, M. S., Metwaly, A. M., Belal, A., Mehany, A. B. M., Elhendawy, M. A., Radwan, M. M., Yassin, A. M., El-Deeb, N. M., Hafez, E. E., ElSohly, M. A., & Eissa, I. H. (2018). Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors. European Journal of Medicinal Chemistry, 155, 117–134. https://doi.org/10.1016/j.ejmech.2018.06.004
   PubMed Web of Science ®Google Scholar
• Ibrahim, I., & Wally, M. (2010). Synthesis, labeling and biodistribution of 99m Tc3-amino-2-quinoxalin-carbonitrile 1,4-dioxide in tumor bearing mice. Journal of Radioanalytical and Nuclear Chemistry, 285(2), 169–175. https://doi.org/10.1007/s10967-009-0039-1
   Web of Science ®Google Scholar
• Ismail, M. M. F., Amin, K. M., Noaman, E., Soliman, D. H., & Ammar, Y. A. (2010). New quinoxaline 1, 4-di-N-oxides: Anticancer and hypoxia-selective therapeutic agents. European Journal of Medicinal Chemistry, 45(7), 2733–2738. https://doi.org/10.1016/j.ejmech.2010.02.052
   PubMed Web of Science ®Google Scholar
• Jang, D., Lee, A.-H., Shin, H.-Y., Song, H.-R., Park, J.-H., Kang, T.-B., Lee, S.-R., & Yang, S.-H. (2021). The role of tumor necrosis factor alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics. International Journal of Molecular Sciences, 22(5), 2719. https://doi.org/10.3390/ijms22052719
   PubMed Web of Science ®Google Scholar
• Jeon, K.-H., Park, S., Jang, H. J., Hwang, S.-Y., Shrestha, A., Lee, E.-S., & Kwon, Y. (2021). AK-I-190, a new catalytic inhibitor of topoisomerase ii with anti-proliferative and pro-apoptotic activity on androgen-negative prostate cancer cells. International Journal of Molecular Sciences, 22(20), 11246. https://doi.org/10.3390/ijms222011246
   PubMed Web of Science ®Google Scholar
• Kaplum, V., Cogo, J., Sangi, D. P., Ueda-Nakamura, T., Corrêa, A. G., & Nakamura, C. V. (2016). In vitro and in vivo activities of 2,3-diarylsubstituted quinoxaline derivatives against Leishmania amazonensis. Antimicrobial Agents and Chemotherapy, 60(6), 3433–3444. https://doi.org/10.1128/AAC.02582-15
   PubMed Web of Science ®Google Scholar
• Khalifa, M. M., Al-Karmalawy, A. A., Elkaeed, E. B., Nafie, M. S., Tantawy, M. A., Eissa, I. H., & Mahdy, H. A. (2022). Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: Design, synthesis, anti-proliferative, docking, and in vivo studies. Journal of Enzyme Inhibition and Medicinal Chemistry, 37(1), 299–314. https://doi.org/10.1080/14756366.2021.2007905
   PubMed Web of Science ®Google Scholar
• Kumar, A., Singh, A. K., Singh, H., Vijayan, V., Kumar, D., Naik, J., Thareja, S., Yadav, J. P., Pathak, P., Grishina, M., Verma, A., Khalilullah, H., Jaremko, M., Emwas, A.-H., & Kumar, P. (2023). Nitrogen containing heterocycles as anticancer agents: A medicinal chemistry perspective. Pharmaceuticals (Basel, Switzerland), 16(2), 299. https://doi.org/10.3390/ph16020299
   PubMedGoogle Scholar
• Li, J., & Yuan, J. (2008). Caspases in apoptosis and beyond. Oncogene, 27(48), 6194–6206. https://doi.org/10.1038/onc.2008.297
   PubMed Web of Science ®Google Scholar
• Lin, J., Wang, P., Zhang, Z., Xue, G., Zha, D., Wang, J., Xu, X., & Li, Z. (2020). Facile synthesis and anti-proliferative activity evaluation of quinoxaline derivatives. Synthetic Communications, 50(6), 823–830. https://doi.org/10.1080/00397911.2020.1714054
   Web of Science ®Google Scholar
• Liu, Q.-Q., Lu, K., Zhu, H.-M., Kong, S.-L., Yuan, J.-M., Zhang, G.-H., Chen, N.-Y., Gu, C.-X., Pan, C.-X., Mo, D.-L., & Su, G.-F. (2019). Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo. European Journal of Medicinal Chemistry, 165, 293–308. https://doi.org/10.1016/j.ejmech.2019.01.004
   PubMed Web of Science ®Google Scholar
• Lv, H., Wang, F., Reddy, M. V. R., Zhou, Q., Zhang, X., Reddy, E. P., & Gallo, J. M. (2012). Screening candidate anticancer drugs for brain tumor chemotherapy: Pharmacokinetic-driven approach for a series of (E)-N-(substituted aryl)-3-(substituted phenyl)propenamide analogues. Investigational New Drugs, 30(6), 2263–2273. https://doi.org/10.1007/s10637-012-9806-x
   PubMed Web of Science ®Google Scholar
• Madia, V. N., Nicolai, A., Messore, A., De Leo, A., Ialongo, D., Tudino, V., Saccoliti, F., De Vita, D., Scipione, L., Artico, M., Taurone, S., Taglieri, L., Di Santo, R., Scarpa, S., & Costi, R. (2021). Design, synthesis and biological evaluation of new pyrimidine derivatives as anticancer agents. Molecules (Basel, Switzerland), 26(3), 771. https://doi.org/10.3390/molecules26030771
   PubMed Web of Science ®Google Scholar
• Min, K. N., Joung, K. E., Kim, D.-K., & Sheen, Y. Y. (2012). Anticancer Effect of 3-(4-dimethylamino phenyl)-N-hydroxy-2-propenamide in MCF-7 Human Breast Cancer. Environmental Health and Toxicology, 27, e2012010. https://doi.org/10.5620/eht.2012.27.e2012010
   PubMedGoogle Scholar
• Montana, M., Montero, V., Khoumeri, O., & Vanelle, P. (2020). Quinoxaline derivatives as antiviral agents: A systematic review. Molecules (Basel, Switzerland), 25(12), 2784. https://doi.org/10.3390/molecules25122784
   PubMed Web of Science ®Google Scholar
• Morjaria, S., Deleuze-Masquefa, C., Lafont, V., Gayraud, S., Bompart, J., Bonnet, P. A., & Dornand, J. (2006). Impairment of TNF-α production and action by Imidazo[1,2-α] quinoxalines, as derivative family which displays potential anti-inflammatory properties. International Journal of Immunopathology and Pharmacology, 19(3), 525–538. https://doi.org/10.1177/039463200601900308
   PubMed Web of Science ®Google Scholar
• Nafie, M. S., Khodair, A. I., Hassan, H. A. Y., El-Fadeal, N., M. A., Bogari, H. A., Elhady, S. S., & Ahmed, S. A. (2021). Evaluation of 2-thioxoimadazolidin-4-one derivatives as potent anticancer agents through apoptosis induction and antioxidant activation: In vitro and in vivo approaches. Molecules (Basel, Switzerland), 27(1), 83. https://doi.org/10.3390/molecules27010083
   PubMed Web of Science ®Google Scholar
• Nelson, W. G., Haffner, M. C., & Yegnasubramanian, S. (2018). The structure of the nucleus in normal and neoplastic prostate cells: Untangling the role of type 2 DNA topoisomerases. American Journal of Clinical and Experimental Urology, 6(2), 107–113.
   PubMedGoogle Scholar
• Nikoletopoulou, V., Markaki, M., Palikaras, K., & Tavernarakis, N. (2013). Crosstalk between apoptosis, necrosis and autophagy. Biochimica et Biophysica Acta, 1833(12), 3448–3459. https://doi.org/10.1016/j.bbamcr.2013.06.001
   PubMed Web of Science ®Google Scholar
• Omuse, G., Maina, D., Mwangi, J., Wambua, C., Radia, K., Kanyua, A., Kagotho, E., Hoffman, M., Ojwang, P., Premji, Z., Ichihara, K., & Erasmus, R. (2018). Complete blood count reference intervals from a healthy adult urban population in Kenya. PLoS One, 13(6), e0198444. https://doi.org/10.1371/journal.pone.0198444
   PubMed Web of Science ®Google Scholar
• Osmaniye, D., Hıdır, A., Sağlık, B. N., Levent, S., Özkay, Y., & Kaplancıklı, Z. A. (2022). Synthesis of new pyrimidine-triazole derivatives and investigation of their anticancer activities. Chemistry & Biodiversity, 19(8), e202200216. https://doi.org/10.1002/cbdv.202200216
   PubMed Web of Science ®Google Scholar
• Pandey, D. K., Devadoss, T., Modak, N., & Mahesh, R. (2016). Antidepressant & anxiolytic activities of N-(pyridin-3-yl) quinoxalin-2-carboxamide: A novel serotonin type 3 receptor antagonist in behavioural animal models. The Indian Journal of Medical Research, 144(4), 614–621. https://doi.org/10.4103/0971-5916.200893
   PubMedGoogle Scholar
• Pearce, S. (2017). The importance of heterocyclic compounds in anticancer drug design. Drug Discovery World, 18, 66–70.
   Google Scholar
• Pfeffer, C. M., & Singh, A. T. K. (2018). Apoptosis: A target for anticancer therapy. International Journal of Molecular Sciences, 19(2), 448. https://doi.org/10.3390/ijms19020448
   PubMed Web of Science ®Google Scholar
• Pommier, Y., Leo, E., Zhang, H., & Marchand, C. (2010). DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chemistry & Biology, 17(5), 421–433. https://doi.org/10.1016/j.chembiol.2010.04.012
   PubMed Web of Science ®Google Scholar
• Remiszewski, S. W., Sambucetti, L. C., Bair, K. W., Bontempo, J., Cesarz, D., Chandramouli, N., Chen, R., Cheung, M., Cornell-Kennon, S., Dean, K., Diamantidis, G., France, D., Green, M. A., Howell, K. L., Kashi, R., Kwon, P., Lassota, P., Martin, M. S., Mou, Y., … Atadja, P. (2003). N-Hydroxy-3-phenyl-2-propenamides as Novel Inhibitors of Human Histone Deacetylase with in Vivo Antitumor Activity: Discovery of (2E)-N-Hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824). Journal of Medicinal Chemistry, 46(21), 4609–4624. https://doi.org/10.1021/jm030235w
   PubMed Web of Science ®Google Scholar
• Rodrigues, J. H D S., Ueda-Nakamura, T., Corrêa, A. G., Sangi, D. P., & Nakamura, C. V. (2014). A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi. PloS One, 9(1), e85706. https://doi.org/10.1371/journal.pone.0085706
   PubMed Web of Science ®Google Scholar
• Rubin, M. A., Maher, C. A., & Chinnaiyan, A. M. (2011). Common gene rearrangements in prostate cancer. Journal of Clinical Oncology, 29(27), 3659–3668. https://doi.org/10.1200/JCO.2011.35.1916
   PubMed Web of Science ®Google Scholar
• S., Hamad Elgazwy., & A.-S., Soliman, D. H. (2013). Design, synthesis and evaluation of 1,3,2 diazaphosphorin[4,5-b]quinoxaline-5,10-di-n-oxide derivatives as novel VEGFR-2 and SRC kinase inhibitors in the treatment of prostate cancer. The Open Conference Proceedings Journal, 4, 77–86. https://doi.org/10.2174/2210289201304010077
   Google Scholar
• Salam, H. S., Tawfik, M. M., Elnagar, M. R., Mohammed, H. A., Zarka, M. A., & Awad, N. S. (2022). Potential apoptotic activities of Hylocereus undatus peel and pulp extracts in MCF-7 and Caco-2 cancer cell lines. Plants (Basel, Switzerland), 11(17), 2192. https://doi.org/10.3390/plants11172192
   PubMedGoogle Scholar
• Salazar, J. H. (2014). Overview of urea and creatinine. Laboratory Medicine, 45(1), e19–e20. https://doi.org/10.1309/LM920SBNZPJRJGUT
   Google Scholar
• Seth, A., & Watson, D. K. (2005). ETS transcription factors and their emerging roles in human cancer. European Journal of Cancer (Oxford, England: 1990), 41(16), 2462–2478. https://doi.org/10.1016/j.ejca.2005.08.013
   PubMed Web of Science ®Google Scholar
• Sri Ramya, P. V., Guntuku, L., Angapelly, S., Karri, S., Digwal, C. S., Babu, B. N., Naidu, V. G. M., & Kamal, A. (2018). Curcumin inspired 2-chloro/phenoxy quinoline analogues: Synthesis and biological evaluation as potential anticancer agents. Bioorganic & Medicinal Chemistry Letters, 28(5), 892–898. https://doi.org/10.1016/j.bmcl.2018.01.070
   PubMed Web of Science ®Google Scholar
• Swift, L., Cutts, S., Nudelman, A., Levovich, I., Rephaeli, A., & Phillips, D. (2008). The cardio-protecting agent and topoisomerase II catalytic inhibitor sobuzoxane enhances doxorubicin-DNA adduct mediated cytotoxicity. Cancer Chemotherapy and Pharmacology, 61(5), 739–749. https://doi.org/10.1007/s00280-007-0528-2
   PubMed Web of Science ®Google Scholar
• Tang, X., He, J., Li, Q., Tang, X., Chen, M., Hao, G., Huai, Z., Huang, Y., & Xue, W. (2020). Discovery of 1,4-pentadien-3-one derivatives containing quinoxaline scaffolds as potential apoptosis inducers. Future Medicinal Chemistry, 12(16), 1505–1519. https://doi.org/10.4155/fmc-2019-0371
   PubMed Web of Science ®Google Scholar
• Tariq, S., Alam, O., & Amir, M. (2018). Synthesis, anti-inflammatory, p38α MAP kinase inhibitory activities and molecular docking studies of quinoxaline derivatives containing triazole moiety. Bioorganic Chemistry, 76, 343–358. https://doi.org/10.1016/j.bioorg.2017.12.003
   PubMed Web of Science ®Google Scholar
• Tawfik, M. M., Eissa, N., Althobaiti, F., Fayad, E., & Abu Almaaty, A. H. (2021). Nomad Jellyfish Rhopilema nomadica venom induces apoptotic cell death and cell cycle arrest in human hepatocellular Carcinoma HepG2 cells. Molecules (Basel, Switzerland), 26(17), 5185. https://doi.org/10.3390/molecules26175185
   PubMed Web of Science ®Google Scholar
• Tomlins, S. A., Laxman, B., Dhanasekaran, S. M., Helgeson, B. E., Cao, X., Morris, D. S., Menon, A., Jing, X., Cao, Q., Han, B., Yu, J., Wang, L., Montie, J. E., Rubin, M. A., Pienta, K. J., Roulston, D., Shah, R. B., Varambally, S., Mehra, R., & Chinnaiyan, A. M. (2007). Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature, 448(7153), 595–599. https://doi.org/10.1038/nature06024
   PubMed Web of Science ®Google Scholar
• Tseng, C.-H., Chen, Y.-R., Tzeng, C.-C., Liu, W., Chou, C.-K., Chiu, C.-C., & Chen, Y.-L. (2016). Discovery of indeno[1,2-b]quinoxaline derivatives as potential anticancer agents. European Journal of Medicinal Chemistry, 108, 258–273. https://doi.org/10.1016/j.ejmech.2015.11.031
   PubMed Web of Science ®Google Scholar
• Upadhyay, K. D., Dodia, N. M., Khunt, R. C., Chaniara, R. S., & Shah, A. K. (2019). Evaluation and in vivo efficacy study of pyrano[3,2-c]quinoline analogues as TNF-α inhibitors. Chemical Biology & Drug Design, 94(3), 1647–1655. https://doi.org/10.1111/cbdd.13566
   PubMed Web of Science ®Google Scholar
• Velidedeoglu, M., Kundaktepe, B. P., Aksan, H., & Uzun, H. (2021). Preoperative fibrinogen and hematological indexes in the differential diagnosis of idiopathic granulomatous mastitis and breast cancer. Medicina (Kaunas, Lithuania), 57(7), 698. https://doi.org/10.3390/medicina57070698
   PubMed Web of Science ®Google Scholar
• Willman, J. H., & Holden, J. A. (2000). Immunohistochemical staining for DNA topoisomerase II-alpha in benign, premalignant, and malignant lesions of the prostate. The Prostate, 42(4), 280–286. https://doi.org/10.1002/(sici)1097-0045(20000301)42:4
   PubMed Web of Science ®Google Scholar
• Wong, R. S. (2011). Apoptosis in cancer: From pathogenesis to treatment. Journal of Experimental & Clinical Cancer Research, 30(1), 87. https://doi.org/10.1186/1756-9966-30-87
   PubMed Web of Science ®Google Scholar
• Zaher, N. H., El-Hazek, R. M. M., El-Gazzar, M. G. M., El-Sabbagh, W. A., & Fadel, N. A. (2023). Novel imino-thiazoloquinoxaline derivatives against renal cell carcinoma: Less radiation-damaging approach. Medicinal Chemistry Research, 32(4), 764–776. https://doi.org/10.1007/s00044-023-03036-8
   Web of Science ®Google Scholar
• Zakzok, S. M., Alkaradawe, R. M., Mohammad, S. H., & Tawfik, M. M. (2021). Anti-proliferative and antioxidant activities of the edible crab Callinectes sapidus hepatopancreas and hemolymph extracts. Egyptian Journal of Aquatic Biology and Fisheries, 25(3), 531–550. https://doi.org/10.21608/ejabf.2021.179659
   Google Scholar
• Zamudio-Vázquez, R., Ivanova, S., Moreno, M., Hernandez-Alvarez, M. I., Giralt, E., Bidon-Chanal, A., Zorzano, A., Albericio, F., & Tulla-Puche, J. (2015). A new quinoxaline-containing peptide induces apoptosis in cancer cells by autophagy modulation †Electronic supplementary information (ESI) available: Supplemental figures, experimental details and characterization data. See DOI:Click here for additional data file. Click here for additional data file. Click here for additional data file. Chemical Science, 6(8), 4537–4549. https://doi.org/10.1039/C5SC00125K
   PubMedGoogle Scholar
• Zhang, J., Zhang, J., Hao, G., Xin, W., Yang, F., Zhu, M., & Zhou, H. (2019). Design, synthesis, and structure–activity relationship of 7-propanamide benzoxaboroles as potent anticancer agents. Journal of Medicinal Chemistry, 62(14), 6765–6784. https://doi.org/10.1021/acs.jmedchem.9b00736
   PubMed Web of Science ®Google Scholar